Redox / Butyrate Oxidation / Thiolase Branch in UC
Main digest: UC Causal Mechanism Digest 007 — Redox, Butyrate Oxidation, Roediger, and Pravda
Working model
sulfide / nitric oxide / oxidative stress / sleep loss / stress / unknown trigger
↓
redox modification of mitochondrial acetoacetyl-CoA thiolase
↓
impaired butyrate oxidation in colonocytes
↓
energy deficit + H2O2 / ROS generation
↓
barrier injury + neutrophil chemotaxis
↓
rectal low-reserve mucus barrier crosses threshold
↓
mucus → constipation/tenesmus/contact time → blood/pain/calprotectinWhy it matters for Paul
This branch may explain:
- why the colon/rectum becomes vulnerable even when symptoms start subtly;
- why mucus may appear before blood;
- why stress and poor sleep can worsen flares;
- why sulfur/sulfide, dairy/meat/processed foods, or microbial metabolites might matter;
- why butyrate is not a simple “more is always better” intervention;
- how Dr. Pravda’s H2O2 model overlaps with Roediger’s starved-gut theory.
Strongest anchor finding
Santhanam et al. 2007 found:
- mitochondrial acetoacetyl-CoA thiolase activity about 80% lower in UC biopsies;
- Crohn’s and controls did not show this same defect;
- other butyrate oxidation enzymes were normal;
- defect did not track severity/treatment;
- reducing agent restored activity ex vivo;
- UC biopsies showed increased H2O2 generation.
This supports a specific UC-linked redox/butyrate-oxidation defect.
How Roediger and Pravda fit together
Roediger/starved-gut frame:
colonocytes need butyrate → butyrate oxidation is impaired → mucosa becomes energy deficientPravda/radical-induction frame:
impaired metabolism/redox → excess epithelial H2O2 → barrier injury + neutrophil chemotaxisCombined safe interpretation:
UC may include a reversible epithelial energy/redox bottleneck that turns normal luminal metabolism into barrier stress.Hydrogen sulfide nuance
Do not oversimplify as “sulfur bad.” Current H2S reviews describe a concentration/context-dependent effect:
- too much H2S may inhibit mitochondrial/butyrate oxidation and damage barrier;
- too little H2S may impair mucus production, repair, and anti-inflammatory signaling;
- detoxification capacity, microbiome, and host enzyme expression matter.
Safety flags
Oral redox-support supplements: NAC vs liposomal glutathione
Paul’s 2026-06-28 supplement shortlist asked about liposomal glutathione. Quick triage did not find direct UC clinical-trial evidence for liposomal glutathione itself. The more evidence-grounded adjacent branch is N-acetylcysteine (NAC), a glutathione precursor/redox-support compound; one randomized UC remission-maintenance trial/preprint reported fewer relapses and lower fecal calprotectin/ESR/hs-CRP during steroid taper.
Safe interpretation: liposomal glutathione belongs in the redox hypothesis bucket, but NAC is currently the cleaner clinician-discussion comparator for UC-specific evidence. See UC Supplement Shortlist — Berberine, Omega-3, Liposomal Glutathione.
Cautions: supplement quality, GI tolerance, current flare status, asthma/bronchospasm history, anticoagulant/bleeding context, and medication interactions matter.
Avoid: hydrogen peroxide enemas
H2O2 is the proposed injurious molecule, not a therapy. Hydrogen peroxide enemas can cause chemical colitis/proctitis and have fatal case-report history.
Avoid: chlorine dioxide / CDS / MMS
Treat chlorine dioxide/CDS/MMS as high-risk, non-evidence-based bleach-like “cure-all” claims with FDA/regulatory warnings.
Caution: RDLA / sodium thiosulfate / reducing-agent enemas
These belong on a clinician-discussion/research-question list, not a DIY protocol list. Dose, sterility, vehicle, formulation, contraindications, interactions, and mucosal injury risk matter.
What would make this personally testable?
Potential tracking/research variables:
- flare timeline: stress, sleep, exercise intensity, infection, antibiotics;
- sulfur/sulfide load: red meat, eggs, cheese, sulfites/processed meats, brassicas if suspected;
- stool contact time: constipation, incomplete evacuation, tenesmus;
- objective inflammation: fecal calprotectin, CRP/ESR;
- oxidative-stress markers if clinician deems useful: F2-isoprostanes, lipid peroxides, glutathione status, antioxidant capacity;
- response to clinician-approved barrier/local therapies.